Tissue Plasminogen Activator connected with Roche dominance expands market

 
Tissue Plasminogen Activator 

Market Overview:


Tissue plasminogen activator (tPA) is a protein involved in the breakdown of blood clots. tPA is produced naturally in cells that line arteries and veins, and it enters the bloodstream in response to injury in order to dissolve clots and prevent larger clots from forming. Recombinant tPA is a manufactured version of tPA produced through biotechnology that is used clinically in the treatment of ischemic strokes. By allowing faster restoration of blood flow, tPA has been shown to significantly improve outcomes for stroke patients when administered within 4.5 hours of symptom onset. The need for swift treatment of ischemic strokes and advantages of recombinant tPA over other thrombolytic agents like increased efficiency and specificity for clots drive demand in the tPA market.

Market key trends:

One of the key trends in the global tPA market is the dominance of Roche's brand Activase. Activase accounted for over 90% of the tPA market share in 2022. The drug has been the gold standard treatment for ischemic strokes for over 30 years. Roche holds valuable patents protecting Activase which is a major barrier for other manufacturers to enter the market. The expiry of these patents after 2023 may see increased competition from biosimilar tPAs. However, Roche's strong brand recognition and reputation are likely to maintain its market leadership position over the forecast period.

Porter’s Analysis Content
Threat of new entrants: The Tissue Plasminogen Activator Market Size has moderate threat of new entrants due to high research costs involved in the development of new drugs and the requirement of strong distribution networks.
Bargaining power of buyers: The bargaining power of buyers is moderate as tissue plasminogen activator is a biological drug without substitutes for treating stroke and acute myocardial infarction.
Bargaining power of suppliers: A few major pharmaceutical companies dominate the supply market. Hence, the bargaining power of suppliers is high in this market.
Threat of new substitutes: Currently, there are no appropriate substitutes available for tissue plasminogen activators. Hence, the threat from substitutes is low.
Competitive rivalry: The tissue plasminogen activator market witnesses high competitive rivalry amongst major players.

Key Takeaways

The global tissue plasminogen activator market is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period 2023-2030, due to increasing incidences of cardiac diseases and strokes. The market was valued at US$ 2.58 Bn in 2023.

Regionally, North America dominated the global tissue plasminogen activator market in 2023 due to rising prevalence of cardiovascular diseases and adoption of tissue plasminogen activator therapy. However, Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to the large patient pool and improving healthcare infrastructure in developing countries of the region.

Key players operating in the tissue plasminogen activator market are F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences. Major players are focusing on new product launches and strategic collaborations to gain higher market share.

Read More:

https://www.dailyprbulletin.com/tissue-plasminogen-activator-market-growth-demand-and-siz/

Comments

Post a Comment

Popular posts from this blog

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv...
Read more